Nature Communications (May 2020)
Author Correction: Immunogenomic profiling determines responses to combined PARP and PD-1 inhibition in ovarian cancer
- Anniina Färkkilä,
- Doga C. Gulhan,
- Julia Casado,
- Connor A. Jacobson,
- Huy Nguyen,
- Bose Kochupurakkal,
- Zoltan Maliga,
- Clarence Yapp,
- Yu-An Chen,
- Denis Schapiro,
- Yinghui Zhou,
- Julie R. Graham,
- Bruce J. Dezube,
- Pamela Munster,
- Sandro Santagata,
- Elizabeth Garcia,
- Scott Rodig,
- Ana Lako,
- Dipanjan Chowdhury,
- Geoffrey I. Shapiro,
- Ursula A. Matulonis,
- Peter J. Park,
- Sampsa Hautaniemi,
- Peter K. Sorger,
- Elizabeth M. Swisher,
- Alan D. D’Andrea,
- Panagiotis A. Konstantinopoulos
Affiliations
- Anniina Färkkilä
- Dana-Farber Cancer Institute
- Doga C. Gulhan
- Harvard Medical School
- Julia Casado
- Research Program in Systems Oncology, University of Helsinki
- Connor A. Jacobson
- Laboratory of Systems Pharmacology, Harvard Medical School
- Huy Nguyen
- Dana-Farber Cancer Institute
- Bose Kochupurakkal
- Dana-Farber Cancer Institute
- Zoltan Maliga
- Laboratory of Systems Pharmacology, Harvard Medical School
- Clarence Yapp
- Laboratory of Systems Pharmacology, Harvard Medical School
- Yu-An Chen
- Laboratory of Systems Pharmacology, Harvard Medical School
- Denis Schapiro
- Laboratory of Systems Pharmacology, Harvard Medical School
- Yinghui Zhou
- TESARO: A GSK company
- Julie R. Graham
- TESARO: A GSK company
- Bruce J. Dezube
- TESARO: A GSK company
- Pamela Munster
- Helen Diller Family Comprehensive Cancer Center
- Sandro Santagata
- Brigham and Women’s Hospital, Laboratory for Systems Pharmacology
- Elizabeth Garcia
- Department of Pathology, Brigham and Women’s Hospital, Harvard Medical School
- Scott Rodig
- Department of Pathology, Brigham and Women’s Hospital, Harvard Medical School
- Ana Lako
- Department of Pathology, Brigham and Women’s Hospital, Harvard Medical School
- Dipanjan Chowdhury
- Dana-Farber Cancer Institute
- Geoffrey I. Shapiro
- Dana-Farber Cancer Institute
- Ursula A. Matulonis
- Dana-Farber Cancer Institute
- Peter J. Park
- Department of Biomedical Informatics, Harvard Medical School
- Sampsa Hautaniemi
- Research Program in Systems Oncology, University of Helsinki
- Peter K. Sorger
- Laboratory of Systems Pharmacology, Harvard Medical School
- Elizabeth M. Swisher
- University of Washington
- Alan D. D’Andrea
- Dana-Farber Cancer Institute
- Panagiotis A. Konstantinopoulos
- Dana-Farber Cancer Institute
- DOI
- https://doi.org/10.1038/s41467-020-16344-z
- Journal volume & issue
-
Vol. 11,
no. 1
pp. 1 – 1
Abstract
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
